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Abstract
Background: Heart failure is a chronic condition that commonly results in frequent
hospitalizations and increases risk of mortality (Kotb et al., 2015; Ong et al., 2016;
Pekmezaris et al., 2018). In addition, heart failure places a significant burden on
healthcare costs and utilization of resources (Hale et al., 2016; Kotb et al., 2015; Ong et
al., 2016). Measures to reduce heart failure readmissions, mortality, and overall costs are
needed. Telemedicine interventions may be beneficial in the management of heart failure;
however, the current research provides unclear and inconclusive findings in regard to the
effectiveness of telemedicine interventions on heart failure readmissions and mortality
(Kraai et al., 2016). Aim: The aim of this literature review is to evaluate the impact of
telemedicine interventions on heart failure readmissions and mortality. Methods: A
literature review was conducted using five healthcare-related databases for data
collection. A systematic search process was employed to extract literature that was
relevant and answered the identified clinical question using keywords and specific
inclusion and exclusion criteria. A total of 10 studies met inclusion criteria for critical
appraisal. Results: Study outcomes related to heart failure readmissions and mortality
were mixed. Limitations of the studies as well as direction for future studies were
identified. Conclusions: Synthesized findings from this literature review identify that
telemedicine interventions may improve outcomes in heart failure patients. However,
further research studies are warranted to evaluate the efficacy of telemedicine on heart
failure outcomes.
Keywords: heart failure, telehealth, telemonitoring, telemedicine, readmission,
mortality, intervention, outcome, 30 day
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Impact of Telemedicine on Heart Failure Readmissions and Mortality: A Literature
Review
Heart failure is a chronic condition leading to progressive, impaired cardiac
function (Kotb et al., 2015; Pekmezaris et al., 2018). Individuals with heart failure are at
risk for frequent hospitalizations and have an increased risk of mortality (Kotb et al.,
2015; Ong et al., 2016; Pekmezaris et al., 2018). The negative impact of heart failure on
healthcare costs and utilization is also a rising concern (Hale et al., 2016; Kotb et al.,
2015; Ong et al., 2016). Issues with accessibility, poor transitions of care and monitoring
post-hospitalization are factors associated with this increased burden on the healthcare
system (Koehler et al., 2018; Ong et al., 2016). Interventions aimed at reducing
readmissions and mortality are warranted and an essential component of heart failure
management (Koehler et al., 2018). Technological advances have given rise to innovative
measures utilized in the healthcare setting in an effort to improve health outcomes.
Numerous telemedicine interventions are available and are currently being used in the
management of various illnesses including heart failure. These measures have been
implemented in an effort to reduce disease progression and subsequent hospitalization
through frequent monitoring and increased follow up (Koehler et al., 2018; Kotb et al.,
2015; Pedone et al., 2015). The utilization of telemedicine in heart failure provides a
means to remotely care for heart failure patients; therefore, increasing the timeliness of
care while also improving the quality of the care provided (Koehler et al., 2018).
Research has shown a potential reduction in heart failure-related hospitalizations,
morbidity, and mortality through the use of telemonitoring programs (Hale et al., 2016;
Kotb et al., 2015; Ong et al., 2016; Pedone et al., 2015). Additionally, it is suggested that
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telemedicine technologies may reduce overall costs related to heart failure (Kotb et al.,
2015; Ong et al., 2016; Pedone et al., 2015). However, findings from current research
studies are often inconsistent or inconclusive (Koehler et al., 2018; Long et al., 2017;
Pedone et al., 2015). Moreover, there have been no significant improvements in health
outcomes among heart failure patients despite these technological advancements (Son et
al., 2020). Innovative methods to improve the care of patients with heart failure, reduce
hospital readmissions, and reduce overall mortality are necessary. Further research
focusing on interventions for heart failure management and dissemination of findings are
needed to guide healthcare providers to best care for heart failure patients. The purpose of
this literature review is to identify and synthesize findings related to the impact of
telemedicine interventions on heart failure readmissions and mortality. Another goal of
this review is to identify findings that can be used to help guide current and future
practice related to heart failure management.
Background
Prevalence of Heart Failure
As many as 6 million Americans have been diagnosed with heart failure (Hale et
al., 2016; Long et al., 2017; Ong et al., 2016; Pekmezaris et al., 2018). Moreover, the
overall prevalence of heart failure is increasing, with an additional 555,000 individuals
being diagnosed every year (Hale et al., 2016; Long et al., 2017; Ong et al., 2016;
Pekmezaris et al., 2018; Son et al., 2020). Additionally, the total number of individuals
diagnosed with heart failure is projected to increase 46% by the year 2030 (Son et al.,
2020). Older individuals, especially, have a higher incidence of heart failure, with nearly
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10 out of 1,000 adults aged 65 and older diagnosed (Long et al., 2017; Pekmezaris et al.,
2018; Son et al., 2020).
Heart Failure Prognosis
Heart failure patients are frequently hospitalized and are six times more likely to
be hospitalized compared to those without heart failure (Long et al., 2017; Ong et al.,
2016). Additionally, heart failure patients who are discharged are frequently readmitted
(Hale et al., 2016; Ong et al., 2016). Research demonstrates that 13% of discharged
patients are readmitted within 15 days, 25% are readmitted within 30 days, and almost
50% are readmitted within six months of hospital discharge (Hale et al., 2016).
Individuals with heart failure are also at an increased risk of mortality, with one in nine
deaths being attributed to heart failure (Hale et al., 2016; Kotb et al., 2015; Ong et al.,
2016). Lastly, individuals aged 65 and older account for 80% of heart failure
hospitalizations and 90% of deaths related to heart failure (Son et al., 2020).
Burden on Costs and Healthcare Utilization
Heart failure has a tremendous impact on healthcare utilization and expenditure
(Pekmezaris et al., 2018). Additionally, it has been identified as the leading cause of
hospital admissions, especially among adults 65 years of age and older (Hale et al., 2016;
Long et al., 2017). The annual cost of managing heart failure is over $100 billion dollars
(Pekmezaris et al., 2018). Moreover, roughly 34% of Medicare spending is targeted
toward heart failure (Long et al., 2017). As a result of the Affordable Care Act, hospitals
may experience decreased payments from the Centers for Medicare and Medicaid
Services as a result of excessive readmissions related to heart failure (Long et al., 2017;
Ong et al., 2016). Furthermore, costs related to heart failure are expected to trend upward,
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with hospitalizations being a major contributor (Hale et al., 2016; Long et al., 2017;
Pekmezaris et al., 2018). However, current methods aimed at reducing hospital
readmissions have proven challenging (Koehler et al., 2018). As a result of the negative
impact of heart failure on costs and healthcare utilization, identification of specific
interventions are necessary to reduce this burden on the healthcare system (Long et al.,
2017; Pekmezaris et al., 2018).
Heart Failure Management
Self-management is a complex process and a major component in chronic heart
failure management (Hale et al., 2016; Long et al., 2017). Patients are required to engage
in self-care behaviors including frequent monitoring of their weight, recording symptoms,
adhering to medication regimens, and modifying their lifestyle to attain positive health
outcomes (Son et al., 2020). Research findings suggest that medication adherence is
directly related to heart failure outcomes (Hale et al., 2016). Poor medication adherence
ultimately contributes to increased risk for hospitalization and mortality, and increased
costs (Hale et al., 2016). Many factors contribute to poor medication adherence in heart
failure patients including complex medication regimens and memory issues among older
adults (Hale et al., 2016). Measures to improve medication adherence, self-care, and selfmanagement are necessary to improve outcomes (Hale et al., 2016). Many telehealth
interventions that have been utilized in the management of heart failure may lead to a
reduction in hospital readmissions and overall mortality (Hale et al., 2016). However,
specific telemedicine interventions that can improve these outcomes need to be identified.
Definitions
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Telehealth. Telehealth encompasses delivering healthcare services through
technological devices (Hale et al., 2016; Pekmezaris et al., 2018). It can be useful for
communicating, providing education, coordinating care, and enhancing disease selfmanagement and self-care (Hale et al., 2016; Pekmezaris et al., 2018).
Telemedicine. Telemedicine incorporates remote care delivery via technology in
order to provide more accessible healthcare, improve the quality of care provided, and
reduce healthcare costs (Hale et al., 2016). These interventions may include structured
telephone support, telemonitoring systems, video monitoring, medication dispensers,
Bluetooth capable devices that monitor biometrics, and telemedicine systems that allow
ECG transmissions (Kotb et al., 2015; Long et al., 2017).
Telemonitoring. Telemonitoring is a telehealth intervention that allows for
remote monitoring of various measurements from a centralized location to the healthcare
setting (Hale et al., 2016; Pekmezaris et al., 2018). These measurements can include
weight, vital signs, and patient-reported symptoms (Hale et al., 2016). Remote
monitoring interventions provide a means to adjust medication regimens, provide patient
education, and detect signs of deterioration earlier on (Koehler et al., 2018).
Clinical Phenomenon of Interest
The author of this literature review cultivated a spirit of inquiry in which a clinical
phenomenon of interest was identified (Melnyk & Fineout-Overholt, 2019). The author
identified a wide range of telemedicine technologies used in the management of heart
failure that appear promising (Pekmezaris et al., 2018). However, their effectiveness in
reducing heart failure readmissions and mortality remains unclear (Koehler et al., 2018;
Long et al., 2017). The clinical phenomenon of interest specific to this literature review is
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the use of telemedicine and its role in the management of heart failure. Of particular
interest, is the impact of telemedicine interventions on heart failure readmissions and
mortality.
Clinical Question
A clinical question was developed for this literature review based on the clinical
phenomenon of interest pertaining to the impact of telemedicine interventions on heart
failure outcomes. The health outcomes evaluated were heart failure-related readmissions
and mortality. The clinical question was formatted and structured in PICOT format
(P=population, I=intervention, C=comparison, O=outcome, T=time) outlined by Melnyk
and Fineout-Overholt (2019) in an effort to obtain relevant evidence from the current
literature. The clinical PICO(T) question posed for this literature review was as follows:
In adult heart failure patients (P), does the use of telemedicine interventions (I)
compared to standard care without the use of telemedicine interventions (C) impact
hospital readmissions and overall mortality (O)?
Clinical Significance for Advanced Practice Providers
Self-management in heart failure is a complex process. Advanced practice
providers have a key role in assisting heart failure patients to achieve positive health
outcomes as they work closely with this patient population. However, there are several
factors that may hinder effective heart failure management including accessibility and
poor care transitions post-hospitalization (Long et al., 2017; Ong et al., 2016).
Additionally, heart failure has been identified as a significant public health issue resulting
in frequent hospitalizations and increased mortality rates (Pekmezaris et al., 2018). The
burden on costs and healthcare utilization is also a rising concern. Changes to
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reimbursements and penalties related to excessive readmissions in heart failure patients
have mandated healthcare providers to identify effective measures to lower readmission
rates (Long et al., 2017; Ong et al., 2016; Pekmezaris et al., 2018). These issues require
advanced practice providers to be knowledgeable about best practices to reduce heart
failure readmissions, mortality rates, and healthcare costs and utilization while improving
the overall quality of care for heart failure patients. Therefore, evaluating the
effectiveness of telemedicine on heart failure outcomes can assist in guiding current
practice (Long et al., 2017). Additionally, previous studies have identified a potential
reduction in hospital readmissions among heart failure patients and mortality through
specific telemedicine interventions (Ong et al., 2016). The use of various telemedicine
technologies could prove valuable in standardizing care among heart failure patients,
improving care transitions, increasing access to care, and decreasing hospital readmission
rates (Long et al., 2017). Thus, the purpose of this literature review is to identify
telemedicine interventions that may be effective in improving health outcomes among
heart failure patients.
Methods
Search Strategies
A total of five databases related to medicine, nursing, allied health, and healthcare
were selected for this literature review. Databases included in the search included
PubMed, CINAHL Plus (with full text), Nursing and Allied Health Database (Formerly
ProQuest Nursing and Allied Health Source), Academic Search Premier (ASP), and the
Cochrane Database of Systematic Reviews. Date ranges included in the database searches
were limited to publication dates between 2015 and 2020. Refer to Table A1 in the
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Appendix for further information on the databases utilized in the search process and the
general subjects covered by the databases selected. The search process was restricted to
articles that were free, full-text, from scholarly academic journals, were peer-reviewed, in
the English language, and included the adult (18+) patient population. Refer to Table A1
in the Appendix for additional search restrictions employed per database.
Data Abstraction Process
A systematic and comprehensive search of the literature was conducted utilizing
the previously mentioned databases. The literature was searched on November 14th, 2020
and November 15th, 2020 for the most current evidence that would answer the clinical
PICO(T) question posed (Melnyk & Fineout-Overholt, 2019). Keywords and keyword
combinations were entered into each database using the Boolean operators. The keywords
and keyword combinations included in the search process were “heart failure” AND
“telehealth”, “heart failure” AND “telehealth” OR “telemonitoring” OR “telemedicine”
AND “readmission” AND “mortality”, “heart failure” AND “telehealth” AND
“readmission” AND “mortality”, “heart failure” AND “telemedicine” AND
“intervention” AND “readmission” AND “mortality” AND “outcome”, and “heart
failure” AND “telemedicine” AND “intervention” AND “readmission” AND “30 day”
AND “mortality” AND “outcome”. Initial hits from the search were substantial. Thus,
search results from each database were further narrowed to a manageable number of
articles utilizing these specific keywords and keyword combinations. Hits of less than 50
articles as a result of these keywords and keyword combinations were further reviewed
for inclusion or exclusion based on the criteria used for this literature review. Duplicate
articles were removed. Refer to Table A2 in the Appendix for detailed information on the
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data abstraction process and the results from each database using these keywords and
keyword combinations.
Literature Review Process
A total of 15 articles were reviewed for inclusion and exclusion criteria from
PubMed, 48 from CINAHL, 45 from Nursing and Allied Health, 43 from Academic
Search Premier, and two articles from the Cochrane Database of Systematic Reviews.
Specific details related to each study were thoroughly reviewed including study purpose,
population, setting, sample size, design, level of evidence, variables, instruments,
interventions as well as primary and secondary outcomes. Studies were limited to either
level I or level II evidence based on the hierarchy of evidence (Melnyk and FineoutOverholt, 2019). Studies that were directly related to the targeted heart failure population,
incorporated the use of telemedicine modalities, and addressed heart failure-related
hospital readmissions and mortality rates were included in this literature review. Studies
were excluded if the heart failure population was not the population of interest and if
outcomes were evaluated among multiple patient populations or disease processes such
as COPD. Studies that did not specifically evaluate the impact of telemedicine on heart
failure readmissions and mortality as a primary or secondary outcome were also
excluded. Additional studies were excluded if they did not meet the criteria for level I or
II evidence (Melnyk & Fineout-Overholt, 2019). Furthermore, studies were excluded if
they involved study designs or study protocols. Refer to Table A3 in the Appendix for
further details pertaining to the included and excluded studies and the author’s rationale
for inclusion or exclusion.
Methodological Assessment
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A total of 10 articles were yielded from the search process for critical appraisal.
The studies included five randomized controlled trials. There were two systematic
reviews and four studies that were a combined systematic review and meta-analysis.
Studies that were either level I or level II evidence and pertinent to the clinical PICO(T)
question were retained and evaluated (Melnyk & Fineout-Overholt, 2019). Refer to Table
A4 in the Appendix for detailed information on the types of studies included in this
literature review.
Overall, there were no identified issues with bias within the search process.
Despite using strategic search methods, it is possible that articles relevant to this literature
review were not identified due to the specific keywords employed in the search process.
The keywords utilized may have limited the search results as there are a variety of terms
used to describe telemedicine as well as a multitude of telemedicine interventions
available that may not have been specified in the keywords and keyword combinations
utilized.
Literature Review
The following literature review will provide a synthesis of the current available
evidence pertaining to the clinical phenomenon of interest and answering the clinical
PICO(T) question posed. This literature review will identify the characteristics of the
studies included and synthesize findings related to the impact of telemedicine in heart
failure management and health outcomes. More specifically, this literature review will
identify findings related to the effect of telemedicine interventions in reducing heart
failure readmissions and mortality.
Study Characteristics
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As previously outlined, there were a total of 10 studies that met the eligibility
criteria for inclusion and were critically appraised for this literature review. The studies
yielded were level I or level II evidence and were published between 2015 and 2020.
There were five randomized controlled trials, two systematic reviews, and four combined
systematic reviews and meta-analyses. Sample sizes among the studies included in this
literature review ranged from 25 to 51,014. There were seven studies with sample sizes
over 1,400. Only three of the studies had sample sizes of less than 200.
The included studies evaluated a form of telemedicine intervention in adult (18+)
patients with heart failure in the outpatient setting. Among these studies, four of them
evaluated the use of a non-invasive telemonitoring system that transmitted patient data to
the healthcare team (Koehler et al., 2018; Kraai et al., 2016; Long et al., 2017;
Pekmezaris et al., 2018). There were two studies that evaluated the use of structured
telephone support and non-invasive home telemonitoring devices (Inglis et al., 2015;
Pedone et al., 2015). Son et al. (2020) utilized mobile phone-based interventions, which
included voice call, telemonitoring, and short message services (SMS). A MedSentry
remote medication monitoring system was evaluated in heart failure management in the
Hale et al. (2016) study. Kotb et al. (2015) evaluated the use of telephone support with
telemonitoring, video monitoring, and electrocardiogram (ECG) monitoring. The final
study evaluated the effectiveness of health coaching telephone calls along with
telemonitoring (Ong et al., 2016).
The primary end outcomes of a majority of the studies included all-cause
hospitalizations, heart failure-related hospitalizations, all-cause mortality, and heart
failure-related mortality (Hale et al., 2016; Inglis et al., 2015; Koehler et al., 2018; Kotb
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et al., 2015). Ong et al. (2016) assessed all-cause readmissions within 30 and 180 days
from hospital discharge, all-cause mortality at 30 and 180 days, and quality of life at 30
and 180 days. Long et al. (2017) was the only other study that evaluated the impact of
telemonitoring on 30-day hospital readmissions. Pekmezaris et al. (2018) specifically
assessed all-cause mortality at 180 days and 365 days, all-cause hospitalizations at 90 and
180 days, and heart failure-related hospitalizations at 180 days. Pedone et al. (2015) also
assessed hospital readmissions and mortality at 180 days. In the Koehler et al. (2018)
study, percent of days lost as a result of an unplanned admission and mortality were also
evaluated. Additional outcomes assessed in the Inglis et al. (2015) study included hospital
length of stay (LOS), health-related quality of life (HRQL), heart failure knowledge and
self-care, acceptability, and costs. Emergency department (ED) visits, medication
adherence, and HRQL were additional outcomes assessed in the Hale et al. (2016) study.
Furthermore, Kraai et al. (2016) evaluated the total and duration of hospital admissions as
well as the number of outpatient visits to the heart failure clinic, change in HRQL, and
cost analyses.
Synthesis of Research on Hospitalization and Readmissions
Hale et al. (2016) demonstrated a significant decrease in the rate of all-cause
hospitalizations and hospital LOS in the intervention arm compared to the control.
However, there were no differences noted in regard to ED visits as well as heart failurerelated and non-heart failure-related hospitalizations (Hale et al., 2016). In the Inglis et al.
(2015) systematic review, both non-invasive telemonitoring and structured telephone
support lowered heart failure-related hospitalizations; however, there was no reduction in
the risk of all-cause hospitalizations. Koehler et al. (2018) found that the remote
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monitoring group had a lower percentage of days lost related to unplanned heart failurerelated readmissions. In the Kotb et al. (2015) systematic review and meta-analysis, there
was no significant reduction in all-cause hospitalization among the intervention groups.
However, there was a significant reduction in heart failure-related hospitalizations among
the intervention groups, which included structured telephone support, telemonitoring, and
telemedicine along with ECG transmission (Kotb et al., 2015). Additionally, reductions
in hospitalizations were noted in the Pedone et al. (2015) study through the use of a
physician-led telemonitoring program.
In the systematic review and meta-analysis by Son et al. (2020), there were no
significant reductions in hospital readmissions using mobile phone-based interventions.
However, there was a significant reduction in hospital LOS (Son et al., 2020). The IN
TOUCH study by Kraai et al. (2015) did not show significant benefits from the use of
telemonitoring in preventing heart failure-related readmissions. The Long et al. (2017)
systematic review showed mixed results. There were some differences noted regarding
readmissions in some of the studies. However, these studies lacked an adequate sample
size (Long et al., 2017). In the BEAT-HF study, there was no significant difference in allcause 30-day or 180-day readmissions using health coaching, telephone calls in addition
to telemonitoring (Ong et al., 2016). All-cause hospitalizations at 90 and 180 days were
not impacted by telemonitoring in the Pekmezaris et al. (2018) systematic review and
meta-analysis. Additionally, Pekmezaris et al. (2018) identified that heart failure-related
hospitalizations at 180 days were not significantly reduced in the intervention group.
Synthesis of Research on Mortality
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In the Inglis et al. (2015) systematic review, all-cause mortality was lowered
using non-invasive telemonitoring and structured telephone support. The TIM-HF2 study
by Koehler et al. (2018) demonstrated a decreased percentage of days lost as a result of
all-cause mortality in the remote monitoring group compared to the standard care group.
However, no significant difference was noted in the percentage of days lost as a result of
heart failure-related mortality (Koehler et al., 2018). The systematic review and metaanalysis by Kotb et al. (2015) identified that both structured telephone support as well as
telemonitoring significantly lowered the risk of all-cause mortality among the
intervention groups; however, this was more notable among the telemonitoring group.
There were no significant differences noted between the groups using the other
telemedicine interventions on all-cause mortality (Kotb et al., 2015). In the Long et al.
(2017) systematic review, there was a 50% reduction in mortality among the
telemonitoring group in one of the studies included in the review. The systematic review
and meta-analysis by Pekmezaris et al. (2018) noted a 40% decrease in 180-day all-cause
mortality in the telemonitoring group. Additionally, two studies demonstrated a 61%
reduction in heart failure-related mortality at 180 days (Pekmezaris et al., 2018).
However, there was no significant reduction in all-cause mortality at 365 days
(Pekmezaris et al., 2018). The physician-led, telemonitoring program in the Pedone et al.
(2015) study also demonstrated effectiveness in reducing 180-day mortality. Moreover,
the systematic review and meta-analysis by Son et al. (2020) found a reduction in risk of
mortality using mobile phone-based interventions; however, pooled results demonstrated
low heterogeneity. The IN TOUCH study by Kraai et al. (2015) did not find any
significant benefits related to all-cause mortality in the telemonitoring group. Lastly,
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there were no differences in 180-day all-cause mortality noted between the groups in the
BEAT-HF study (Ong et al., 2016).
Quality Indicators and Strength of Search
The search methods employed for this literature review were comprehensive in
nature. Search results were reviewed for level of evidence and critically appraised for
inclusion in this review. The research articles utilized for this review were limited to peer
reviewed articles from scholarly, academic journals. Furthermore, articles were limited to
level I or II evidence according to the hierarchy of evidence (Melnyk and FineoutOverholt, 2019).
Gaps and Limitations
Lack of an adequate sample size was a common theme identified in many of the
studies that were included (Kraai et al., 2016). Hale et al. (2016) mention issues with
poor recruitment, thus, leading to small sample size. Additionally, poor adherence to the
telemonitoring interventions was noted among participants in the BEAT-HF study (Ong
et al., 2016). In the study by Hale et al. (2016), significant differences in baseline
characteristics consisting of the New York Heart Association (NYHA) classification of
heart failure and HRQL were noted among the participants. Another gap identified in the
literature was the exclusion of individuals likely at increased risk for 30-day readmissions
(Long et al., 2017). Additionally, the subpopulation(s) of heart failure patients that would
most benefit from telemedicine interventions have been ill-defined (Kotb et al., 2015).
Long et al. (2017) mention the inconsistencies and lack of standardized design protocols
among telemonitoring systems leading to poor intervention fidelity. Many previous
studies also only broadly assess the effects of telemedicine interventions in comparison to
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usual care (Kotb et al., 2015). Additionally, the available research comparing
telemedicine interventions is limited (Kotb et al., 2015). Moreover, studies are
consistently focused on telephone support and telemonitoring interventions in the heart
failure population with research lacking in other areas such as video monitoring and ECG
monitoring (Kotb et al., 2015). Long et al. (2017) specifically mentions the lack of
research evaluating the impact of telemedicine interventions on 30-day readmission rates.
A comparison of the cost-effectiveness between the various telemedicine interventions is
also not well known (Kotb et al., 2015). Lastly, the long-term clinical significance of
telehealth interventions on heart failure readmissions and hospitalizations is poorly
understood (Hale et al., 2016; Kotb et al., 2015).
Discussion
The findings from this review demonstrated mixed results. Hale et al. (2016)
noted a significant reduction in all-cause hospitalizations as well as decreased hospital
LOS in the intervention group compared to the standard care group with the use of the
MedSentry medication monitoring system. However, Hale et al. (2016) also noted a
significant reduction in HRQL in the intervention arm. This may be attributed to the
reduced heart failure class and heart function among the intervention participants (Hale et
al., 2016). Overall, findings from the Hale et al. study demonstrate the potential benefits
of implementing medication adherence, telehealth technologies. The systematic review
by Inglis et al. (2015) identified the benefits of structured telephone support as well as
non-invasive home telemonitoring in decreasing the risk of all-cause mortality and heart
failure-related hospitalizations. These interventions were also found to help improve
HRQL, knowledge about heart failure, and self-care behaviors among study participants
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(Inglis et al., 2015). Koehler et al. (2018) found a significant reduction in the number of
days lost due to unplanned hospitalizations as well as a decrease in all-cause mortality
using a structured remote monitoring intervention. There were no improvements noted in
HRQL using the telemonitoring intervention (Koehler et al., 2018). This could be related
to major depression being part of the exclusion criteria (Koehler et al., 2018). In the Kotb
et al. (2015) systematic review and meta-analysis, structured telephone support and
telemonitoring decreased heart failure-related hospitalizations and risk of mortality
compared to usual care. Additionally, ECG monitoring decreased heart failure
hospitalizations (Kotb et al., 2015).
The Pedone et al. (2015) study evaluated the use of a telemonitoring system in
patients 65 and older and found that this intervention resulted in decreased risk of allcause mortality and hospitalization. In the systematic review and meta-analysis by
Pekmezaris et al. (2018), findings included a significant reduction in heart failure-related
mortality and all-cause mortality at 180 days when home telemonitoring was used.
However, Pekmezaris et al. (2018) also noted that the study findings were time dependent
and found that there were no significant reduction in odds at 365 days. Factors that may
account for this include worsening of the disease and poor long-term patient adherence
(Pekmezaris et al., 2018). There were no significant reductions in heart failure-related
hospitalizations or all-cause hospitalizations observed in the study (Pekmezaris et al.,
2018).
Kraai et al. (2015) found no significant reduction in heart failure admissions and
all-cause mortality in the intervention group. The reason for this could be that the
population included in the study sample was relatively healthy (Kraai et al., 2015).
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Although no significant differences were noted in the IN TOUCH study, Kraai et al.
(2015) mention there was a significant decrease in outpatient visits to the heart failure
clinic. Additionally, there was a high rate of adherence to the telemonitoring intervention
(Kraai et al., 2015). This suggests that telemonitoring may be a safe alternative to
outpatient clinic visits and may help to improve accessibility to healthcare (Kraai et al.,
2015). In the systematic review by Long et al. (2017) there were four studies that
demonstrated a difference in readmission rates among heart failure patients; however,
three of the studies lacked an adequate sample size to provide statistical significance. Ong
et al. (2016) did not find a significant benefit from using health coaching, telephone calls
and telemonitoring on readmissions or mortality. Although, there was significant
improvement noted in HRQL at 180 days (Ong et al., 2016). However, Ong et al. (2016)
state that further research is needed to validate these study findings.
Lastly, the systematic review and meta-analysis by Son et al. (2020) did not
demonstrate a significant reduction in hospital readmissions using mobile phone-based
interventions. However, hospital LOS was significantly reduced using the voice call
intervention (Son et al., 2020). One study in the Son et al. (2020) systematic review and
meta-analysis showed a statistically significant difference in disease prevention, lifestyle
modifications, and disease management among the intervention group. There was no
significant benefit noted with the other mobile phone-based interventions on reducing allcause mortality, readmissions, ED visits, or improving HRQL (Son et al., 2020).
However, Son et al. identified inconsistencies with the mobile phone-based interventions
among the studies. Thus, pointing to the fact that variations in the intervention frequency,
intensity, duration, and feedback provided attributed to these inconsistencies. Son et al.
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also mention that the SMS interventions were one-way messages and not interactive.
Additionally, the difficulties that some populations may have with these interventions,
specifically among the elderly population, may have been an issue (Son et al., 2020).
Implications for Future Practice
The current literature was evaluated through this literature review and
recommendations for future direction were made. A compilation of recommendations for
clinical practice, future research, education, and policy follow.
Clinical Practice Recommendations
A wide variety of telemedicine interventions are available for use in the
management of heart failure. Although the results of this literature review were mixed,
telemedicine may be beneficial in improving health outcomes, such as reducing visits to
the heart failure clinic, preventing readmissions, and decreasing days lost as a result of
hospitalization and mortality (Hale et al., 2016; Inglis et al., 2015; Koehler et al., 2018;
Kotb et al., 2015; Kraai et al., 2015; Pedone et al., 2015; Pekmezaris et al., 2018; Son et
al., 2020). Additionally, telemedicine may help to increase access to healthcare services
and improve the HRQL among heart failure patients (Inglis et al., 2015; Kraai et al.,
2015; Long et al., 2017; Pekmezaris et al., 2018). Furthermore, telemedicine may
improve heart failure knowledge and education as well as disease management and selfcare behaviors among patients with heart failure (Inglis et al., 2015; Ong et al., 2016; Son
et al., 2020). Given the current pandemic and more widespread use of telehealth
technologies, advanced practice providers should be knowledgeable and adept at utilizing
telehealth and telemedicine interventions. Additionally, providers should be skilled in
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tailoring interventions to the specific population and age group they are serving while
keeping patient preferences in mind.
Recommendations for Future Research
Future studies specific to the use of telehealth interventions in the heart failure
patient population should focus on gaps and limitations identified in the literature. Small
sample size was a commonly identified limitation (Hale et al., 2016; Pedone et al., 2015;
Son et al., 2020). Subsequently, further studies merit a larger sample size to provide
greater power to the study and to fully appreciate outcomes (Hale et al., 2016; Pedone et
al., 2015). Additionally, Long et al. (2017) mentions a meta-analysis would be beneficial
to evaluate and compare the design of telemonitoring modalities.
Kotb et al. (2015) point out that previous studies have only broadly assessed the
effects of telemedicine in comparison to usual care and the available research comparing
telemedicine interventions to each other is limited. Therefore, future studies should
provide a comparison of the effectiveness of these various modalities (Inglis et al., 2015;
Kotb et al., 2015). Kotb et al. (2015) also mention that a major focus of current research
has been on telephone support and telemonitoring interventions. Newer telemedicine
technologies, such as implantable devices, may be beneficial in improving patient
engagement and adherence as well as providing more detailed health status information
(Ong et al., 2016). Thus, it is pertinent that future studies be conducted utilizing the most
current technologies as well as a broad range of modalities available in telemedicine such
as video monitoring and ECG monitoring (Inglis et al., 2015; Kotb et al., 2015). Inglis et
al. (2015) also discuss needing further research in utilizing closed-loop systems, which
incorporates physiological measurements into decision-support tools.
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Long et al. (2017) mentions the inconsistencies and lack of standardized design
protocols among telemonitoring systems leading to poor intervention fidelity. Inglis et al.
(2015) emphasizes the importance of developing a standardized design for future studies
as well as reporting criteria. Areas for future research should also include testing all
elements of interventions including duration (Pekmezaris et al., 2018). Additionally,
studies should specify whether single interventions or multiple interventions are most
effective (Son et al., 2020). Future studies should also focus on telemedicine and its
effectiveness at specifically reducing 30-day readmissions (Long et al., 2017). Moreover,
the long-term clinical significance of various telehealth interventions on heart failure
outcomes should be addressed (Hale et al., 2016; Kotb et al., 2015).
Previous studies have extensively evaluated health outcomes; however, there is
limited data on economic and societal outcomes including increasing access to care and
reducing disparities among heart failure populations (Inglis et al., 2015; Pedone et al.,
2015; Pekmezaris et al., 2018). A cost-analysis and comparison of various telemedicine
interventions should also be an area of focus in future research (Inglis et al., 2015; Kotb
et al., 2015; Pedone et al., 2015). Moreover, the full benefits of telemonitoring should be
assessed including length and quality of life, reduced travel for patients and healthcare
providers, and improved provider efficiency (Pekmezaris et al., 2018).
In the Hale et al. (2016) study, significant differences were noted among
participants in regard to the NYHA classification of heart failure and HRQL. Thus, it is
suggested that further studies obtain a larger sample size or utilize inclusion and
exclusion criteria that would provide a narrower range of baseline characteristics (Hale et
al., 2016; Pedone et al., 2015). In the Pedone et al. (2015) study, there were significant
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physical impairments noted among the participants in the sample size; therefore, making
generalizability difficult (Pedone et al., 2015). Moreover, a gap identified in the Long et
al. (2017) study was the exclusion of individuals most likely at increased risk for 30-day
readmissions, such as non-English speaking patients or patients with cognitive
impairments. An area of focus for future studies should be on identifying specific
subpopulations of heart failure patients that would most benefit from the telemedicine
interventions (Kotb et al., 2015). Inglis et al. (2015) also identify the potential benefits of
telemonitoring among heart failure patients during end-of-life. Furthermore, the target
age of the participants in future studies should be considered as well as patient
preferences (Inglis et al., 2015; Son et al., 2020).
Education Recommendations
There is an increasing need to identify methods effective at improving heart
failure health outcomes and reducing the burden of heart failure on healthcare costs and
utilization. As innovative telemedicine methods become more prevalent and widely used,
healthcare providers need to be trained to competently utilize telehealth, telemonitoring,
and telemedicine measures to care for various patient populations. Additionally, the
identification of methods to disseminate research findings related to best practices in
heart failure management is necessary.
Recommendations for Policy
Pekmezaris et al. (2018) state that regulation issues, problems with
reimbursement, and other policy issues have hindered the widespread use of telemedicine
in heart failure management. Pekmezaris et al. (2018) also mention that the recent
changes in regulations that relaxed Medicare restrictions of telemedicine only address
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videoconferencing reimbursements and do not address vital signs monitoring. Further
loosening of restrictions pertaining to reimbursement for telehealth services as well as
expansion of telehealth services should remain a priority (Pekmezaris et al., 2018).
Conclusion
The findings from this systematic literature review contribute to the current
knowledge related to the impact of telemedicine in the heart failure population. Although
the findings from this literature review provide mixed results, telemedicine modalities
have the potential to improve outcomes among heart failure patients as well as reduce the
burden on costs and healthcare utilization. Advanced practice providers can utilize the
knowledge provided from this literature review to improve the care of heart failure
patients. Furthermore, findings from this literature review have provided implications for
clinical practice, research, education and policy.
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Telemonitoring
system, Selfrated health
status scale,
Living with
Heart Failure
Questionnaire

Remote patient
management
intervention that
included a daily
weight, blood
pressure, heart
rate, heart rhythm,
SpO2, and selfrated health status

Kotb, A.,
Cameron, C.,
Hsieh, S., &
Wells, G. (2015).
Comparative
effectiveness of

To determine
the impact of
telemedicine
options in heart
failure patients.

Mean age
65/
n=10,193

Systematic
Review and
MetaAnalysis/
LOE I

Usual care,
telemonitoring
interventions,
ECG
transmission

Telephone
support,
telemonitoring,
video monitoring,
or
electrocardiograph
ic monitoring

Findings

cause
hospitalizations. 1
study resulted in
reduced length of
stay.
Fewer days lost
related to
unplanned
hospitalizations
and all-cause
mortality in the
intervention
group. Number of
days lost in the
usual care group
was 24 days.
Number of days
lost in the
intervention group
was 18 days. Allcause mortality is
reduced using
remote patient
management.

A total of 30
RCTs were
included.
Telephone support
resulted in a
reduced odds of
mortality and
hospitalizations.

Implications

Increased risk of
readmission with
remote patient
management,
however, LOS
may be shorter.
The use of a
remote patient
management
intervention could
aid in lowering the
percentage of days
lost due to hospital
admissions and
all-cause
mortality.

The use of
structured
telephone support
and telemonitoring
results in a
significantly
reduced odds of
death and heart
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Findings

Implications

Telemonitoring
resulted in reduced
odds of mortality
and reduced
hospitalizations.
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odds of
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failure related
hospitalization.
Telephone support
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interventions may
be beneficial for
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patients with heart
failure.
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To assess
whether
telemonitoring
aids in
reduction of
heart failure
hospitalizations
and mortality
and if the
addition of an
information and
computing
technology
guided disease
management
system (ICDguided-DMS)
results in
improved
outcomes or
lowers
healthcare
costs.

Adults
18+/Sampl
e size
n=177/
Admission
to intensive
care/corona
ry care unit
or
cardiology
ward or
outpatient
HF clinic

RCT/ LOE II

Questionnaires

ICT-guided-DMS
group and
telemonitoring
group

There was no
benefit found in
all-cause
mortality, HFreadmission, and
change in HRQoL with the use
of telemonitoring
in addition to ICTguided-DMS with
CDSS.

A telemonitoring
intervention can
be a safe and
effective option
especially in rural
or understaffed
areas and can help
reduce HF-related
clinic visits.

Long, G., Babbitt,
A., & Cohn, T.
(2017). Impact of
home
telemonitoring on
30-Day hospital
readmission rates
for patients with
heart failure: A
systematic review.
MedSurg Nursing,
26(5), 337-348.

To assess the
effectiveness of
home
telemonitoring
on 30-day
readmissions in
HF patients

Adults 50+/
Sample size
ranged
from 7048,538/
Eastern
United
States in
health
systems or
home
healthcare
agency

Systematic
Review/
LOE I

Usual postdischarge care/
Equipment that
collected patient
data, phone
surveys

Home
telemonitoring
intervention

Reviewed 6
studies. No
significant
difference in
readmission rates.
50% decrease in
mortality with the
use of home
telemonitoring.

One study showed
a 50% decrease in
mortality with the
use of home
telemonitoring.
Many of the
studies lacked an
adequate sample
size.

Ong, M. K.,
Romano, P. S.,
Edgington, S.,
Aronow, H. U.,
Auerbach, A. D.,
Black, J. T., De
Marco, T.,

To determine
whether
telemonitoring
approaches are
beneficial for
heart failure
patients
following
hospitalization

Hospitalize
d
individuals
50 years
and older/
n-1437/ 6
academic
medical
centers in

RCT/ LOE II

Electronic
equipment that
recorded BP,
HR, symptoms,
and weight.

A combination of
health coaching
telephone calls
and telemonitoring
were used.

Primary outcome
assessed all-cause
readmission within
180 days from
hospital discharge.
Secondary
outcomes assessed
all-cause
readmissions

Novel remote
monitoring
approaches
including
implantable
devices could
increase patient
adherence or
provide improved
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California

Findings

Implications

within 30 days,
all-cause mortality
at 30 and 180
days, and QoL at
30 and 180 days.
Health coaching
telephone calls
plus
telemonitoring
showed no
significant
reduction in 180
day all-cause
mortality after
hospital discharge,
30 day
readmissions, or
180 day mortality
rates.

information after
hospital discharge.
Use of health
coaching and
telemonitoring
may lead to
improved quality
of life at 180 days.

Pedone, C., Rossi,
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Costanzo, L., &
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(2015). Efficacy
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To assess the
effectiveness of
telemonitoring
vital signs and
use of
telephone
support on 6
month survival
and hospital
admissions in
elderly patients
with heart
failure.

Elderly
patients age
65 and
older with
heart
failure/
Sample size
n=90/
geriatric
acute care
ward and
outpatient
clinic in
Rome, Italy

Randomized
trial/ LOE II

Standard care
versus
Telemonitoring
system that
monitors oxygen
saturation, heart
rate, and blood
pressure; ADLs
and NYHA class
were rated using
scales,
Cumulative
Illness Rating
Scale, serum
level of NTproBNP

Telemonitoring
system and
Telephone support
provided by a
geriatrician

Incidence of the
main outcome was
42% in the control
group and 21% in
the intervention
group.

Use of a physician
led telemonitoring
and telephone
support lowers
risk of all –cause
mortality and
hospitalization in
elderly patients
with HF.

Pekmezaris, R.,
Tortez, L.,
Williams, M.,
Patel, V.,
Makaryus, A.,

To assess the
effectiveness of
home
telemonitoring
in heart failure
patients to
lower mortality

Adults 18+/
Sample size
n=4,923

Systematic
Review and
MetaAnalysis/
LOE I

Telemonitoring
and transmission

Home
telemonitoring that
used vital sign
monitoring and
transmission

26 RCTs were
used to assess the
effectiveness of
home
telemonitoring.
Home
telemonitoring

There is a
significant
reduction in heart
failure related and
all-cause mortality
with the use of
home
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To identify the
most effective
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interventions
for heart failure
patients

Adults 18+/
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NA

Systematic
Review and
MetaAnalysis/
LOE I

Hospitalization,
readmission,
hospital days,
costs, ED visits,
survival, NHA
class, LOS, QoL,
self-care
behaviors,
mortality, BNP,
LVEF, ED visits,
all-cause
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medication
adherence

Voice call
intervention,
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and short message
services

Uminski, K.,
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Whitlock, R.,
Ferguson, T.,
Nadurak, S.,
Hochheim, L.,
Tangri, N., &
Rigatto, C.
(2018). Effect of
post-discharge

To assess the
effectiveness of
post-discharge
virtual wards on
hospital
readmissions
and mortality in
heart failure
patients.

Adults 18+/
n=4,820/
NA

Systematic
Review and
MetaAnalysis/
LOE I

Usual care,
telemonitoring

Post discharge
virtual wards via
telephone or
telemonitoring

Findings

Implications

resulted in a
decreased odds of
all-cause mortality
and heart failure
related mortality at
180 days but not at
365 days. A
significant
increased odds of
all-cause
emergency
department visits
were seen with
home
telemonitoring at
180 days. There
was no significant
impact on allcause
hospitalization at
90 or 180 days or
heart failure
related
hospitalization at
180 days.
8 RCTs were
analyzed. Primary
outcomes looked
at all-cause
mortality,
readmission,
emergency
department visits,
hospital LOS, and
quality of life.
Secondary
outcomes include
self-care behaviors
and other clinical
outcomes. Voice
call interventions
had a significant
effect on hospital
length of stays.
There were no
significant impacts
on all-cause
mortality,
readmission,
emergency
department visits,
or quality of life.
6 RCTs were
related to heart
failure patients
exclusively. Post
discharge virtual
wards resulted in a
reduced risk of
mortality.
Additionally, heart
failure related
readmissions were
reduced. All-cause
readmissions were

telemonitoring.

Voice call
interventions are
effective at
reducing hospital
length of stays in
HF patients.
Future studies
needed to
determine the
most effective
mobile phonebased intervention
to improve health
outcomes.

Post discharge
virtual wards
appear to be
beneficial in
reducing all-cause
mortality and heart
failure related
hospital
admissions.
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